Search

Mary M. Lyons

Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1653, 1645
Total Applications
662
Issued Applications
371
Pending Applications
93
Abandoned Applications
224

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17065870 [patent_doc_number] => 20210268085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES [patent_app_type] => utility [patent_app_number] => 17/228579 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 147516 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228579 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228579
Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes Apr 11, 2021 Issued
Array ( [id] => 17783597 [patent_doc_number] => 11406702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-08-09 [patent_title] => Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated [patent_app_type] => utility [patent_app_number] => 17/228699 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28860 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228699 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228699
Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Apr 11, 2021 Issued
Array ( [id] => 19112812 [patent_doc_number] => 20240124562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => MONOCLONAL ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/768818 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768818 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/768818
MONOCLONAL ANTIBODIES AND USES THEREOF Apr 7, 2021 Pending
Array ( [id] => 17183883 [patent_doc_number] => 20210330768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => METHODS OF TREATING FUNGAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/224888 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224888 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/224888
Methods of treating fungal infections Apr 6, 2021 Issued
Array ( [id] => 18436048 [patent_doc_number] => 20230183342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS AND INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/995651 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16848 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995651 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995651
ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS AND INFECTIONS Apr 4, 2021 Pending
Array ( [id] => 18363285 [patent_doc_number] => 20230144876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 17/907531 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907531 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907531
IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Mar 25, 2021 Pending
Array ( [id] => 18701557 [patent_doc_number] => 11788056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Induction of protective immunity against antigens [patent_app_type] => utility [patent_app_number] => 17/213619 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 32 [patent_no_of_words] => 36085 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213619 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/213619
Induction of protective immunity against antigens Mar 25, 2021 Issued
Array ( [id] => 16948312 [patent_doc_number] => 20210207003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => PROCESS TO REDUCE ENDOTOXIN IN GELATIN [patent_app_type] => utility [patent_app_number] => 17/210965 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210965 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210965
PROCESS TO REDUCE ENDOTOXIN IN GELATIN Mar 23, 2021 Abandoned
Array ( [id] => 18642422 [patent_doc_number] => 11766475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Food safety vaccine to control [patent_app_type] => utility [patent_app_number] => 17/207948 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 50607 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207948 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/207948
Food safety vaccine to control Mar 21, 2021 Issued
Array ( [id] => 18298886 [patent_doc_number] => 20230108572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => Method For Treating Cholesterol-Related Diseases [patent_app_type] => utility [patent_app_number] => 17/906110 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906110
Method For Treating Cholesterol-Related Diseases Mar 18, 2021 Abandoned
Array ( [id] => 18340235 [patent_doc_number] => 20230132184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES [patent_app_type] => utility [patent_app_number] => 17/905864 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14824 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -88 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905864 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905864
METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES Mar 11, 2021 Pending
Array ( [id] => 17385978 [patent_doc_number] => 20220033830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => FUNCTIONALIZATION OF ENDOGENOUS BACTERIA [patent_app_type] => utility [patent_app_number] => 17/189113 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189113
FUNCTIONALIZATION OF ENDOGENOUS BACTERIA Feb 28, 2021 Pending
Array ( [id] => 18391689 [patent_doc_number] => 20230159907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => PERFORMANCE-ENHANCED PROTEASE VARIANTS VII [patent_app_type] => utility [patent_app_number] => 17/908554 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908554 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908554
PERFORMANCE-ENHANCED PROTEASE VARIANTS VII Feb 24, 2021 Pending
Array ( [id] => 18685384 [patent_doc_number] => 11781107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => Microorganisms engineered for muconate production [patent_app_type] => utility [patent_app_number] => 17/184580 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8681 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184580 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/184580
Microorganisms engineered for muconate production Feb 23, 2021 Issued
Array ( [id] => 17065880 [patent_doc_number] => 20210268095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/180959 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180959 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180959
ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Feb 21, 2021 Abandoned
Array ( [id] => 18266021 [patent_doc_number] => 20230087263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/800032 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14090 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800032
ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF Feb 15, 2021 Issued
Array ( [id] => 17649941 [patent_doc_number] => 11352655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Method of identification of methicillin-resistant [patent_app_type] => utility [patent_app_number] => 17/170912 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 4914 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170912 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/170912
Method of identification of methicillin-resistant Feb 8, 2021 Issued
Array ( [id] => 17792532 [patent_doc_number] => 20220251623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => Method and apparatus for avoiding false positive coliform testing [patent_app_type] => utility [patent_app_number] => 17/300020 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/300020
Method and apparatus for avoiding false positive coliform testing Feb 8, 2021 Abandoned
Array ( [id] => 16822764 [patent_doc_number] => 20210138057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => Anti-Microbial Immunomodulation [patent_app_type] => utility [patent_app_number] => 17/154536 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35767 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154536
Anti-microbial immunomodulation Jan 20, 2021 Issued
Array ( [id] => 18780187 [patent_doc_number] => 11821898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Rapid test for Lyme bacteria [patent_app_type] => utility [patent_app_number] => 17/152146 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5537 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152146
Rapid test for Lyme bacteria Jan 18, 2021 Issued
Menu